FindTrial
Sign In

Application of endoscopic ultrasound-guided liver biopsy and percutaneous liver biopsy in the diagnosis of chronic liver disease

Application of endoscopic ultrasound-guided liver biopsy and percutaneous liver biopsy in the diagnosis of chronic liver disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049395
Enrollment
Unknown
Registered
2021-08-01
Start date
2021-08-01
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic liver disease

Interventions

Endoscopic ultrasound guided liver puncture group:Endoscopic ultrasound-guided liver biopsy
Percutaneous liver biopsy group:Surface ultrasound-guided percutaneous liver biopsy

Sponsors

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18 to 75 years; 2.Patients with chronic liver disease according with liver puncture indication; 3.Patients can understand and accept the research protocol and voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Severe cardiac and renal dysfunction, uncorrectable severe bleeding and coagulation disorder; 2.Pregnant women; 3.Malignant liver tumor; 4.The researcher believes that there are other situations that are not suitable for this study.

Design outcomes

Primary

MeasureTime frame
Sampling success rate;Quality determination of liver biopsy specimen;—

Secondary

MeasureTime frame
Patient self-feeling evaluation scale;—

Countries

China

Contacts

Public ContactLi Baiwen

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

lbwlunwentougao@163.com+86 18930894343

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026